Literature DB >> 2105072

Is pyrazinamide bactericidal against Mycobacterium tuberculosis?

L B Heifets1, P J Lindholm-Levy.   

Abstract

Bactericidal activity of pyrazinamide (PZA) was tested at pH 5.6 in 7H12 broth against drug-susceptible M. tuberculosis strains. The highest tested concentrations of PZA, 500 and 1,000 micrograms/ml, killed no more than 76% of the bacterial population. These concentrations are more than 32 times greater than the minimal inhibitory concentration (MIC) and the achievable in vivo concentrations. Despite high clinical efficacy of PZA and its so-called sterilizing activity in mouse experiments, this drug is much less bactericidal in vitro than any other known antituberculosis drug.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105072     DOI: 10.1164/ajrccm/141.1.250

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  5 in total

Review 1.  Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections.

Authors:  E Nuermberger; J Grosset
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-13       Impact factor: 3.267

2.  High-content screening technology combined with a human granuloma model as a new approach to evaluate the activities of drugs against Mycobacterium tuberculosis.

Authors:  Mayra Silva-Miranda; Euloge Ekaza; Adrien Breiman; Karim Asehnoune; David Barros-Aguirre; Kevin Pethe; Fanny Ewann; Priscille Brodin; Lluís Ballell-Pages; Frédéric Altare
Journal:  Antimicrob Agents Chemother       Date:  2014-10-27       Impact factor: 5.191

3.  Mechanisms of Pyrazinamide Action and Resistance.

Authors:  Ying Zhang; Wanliang Shi; Wenhong Zhang; Denis Mitchison
Journal:  Microbiol Spectr       Date:  2013

4.  Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability.

Authors:  Shashikant Srivastava; Jotam G Pasipanodya; Claudia Meek; Richard Leff; Tawanda Gumbo
Journal:  J Infect Dis       Date:  2011-10-21       Impact factor: 5.226

Review 5.  Mutations Associated with Pyrazinamide Resistance in Mycobacterium tuberculosis: A Review and Update.

Authors:  Ananthi Rajendran; Kannan Palaniyandi
Journal:  Curr Microbiol       Date:  2022-10-08       Impact factor: 2.343

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.